Challenges for Drug Repurposing in the COVID-19 Pandemic Era

The coronavirus disease (COVID-19) pandemic has affected an estimated 16 million persons and caused 0.6 million deaths worldwide by September 2020. The pandemic has led to a rush to repurpose existing drugs, although the underlying evidence base is of variable quality. The improving knowledge of the...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Front Pharmacol
Главные авторы: Sultana, Janet, Crisafulli, Salvatore, Gabbay, Flic, Lynn, Elizabeth, Shakir, Saad, Trifirò, Gianluca
Формат: Artigo
Язык:Inglês
Опубликовано: Frontiers Media S.A. 2020
Предметы:
Pharmacology
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7677570/
https://ncbi.nlm.nih.gov/pubmed/33240091
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.588654
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы